The French law on "Protection of persons undergoing biomedical research": Implications for the US

被引:6
作者
Berlin, I [1 ]
Gorelick, DA
机构
[1] Univ Paris 06, Pitie Salpetriee Med Sch, Paris, France
[2] NIDA, Clin Pharmacol Sect, Intramural Res Program, NIH, Baltimore, MD USA
关键词
D O I
10.1111/j.1748-720X.2003.tb00106.x
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Describes the French Law and system for human research subject protection, with its advantages and disadvantages, and compares it with the U.S. System. The aim is to improve the latter by identifying aspects of the French system that are potentially worth adapting and adopting.
引用
收藏
页码:434 / 441
页数:8
相关论文
共 19 条
[1]   Financial conflicts get more scrutiny in clinical trials [J].
Agnew, B .
SCIENCE, 2000, 289 (5483) :1266-1267
[2]  
[Anonymous], 1978, BELM REP ETH PRINC G
[3]   Ethics behind closed doors: do research ethics committees need secrecy? [J].
Ashcroft, R ;
Pfeffer, N .
BRITISH MEDICAL JOURNAL, 2001, 322 (7297) :1294-1296
[4]   Breaking the camel's back: Multicenter clinical trials and local institutional review boards [J].
Burman, WJ ;
Reves, RR ;
Cohn, DL ;
Schooley, RT .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (02) :152-157
[5]   What's the price of a research subject? Approaches to payment for research participation [J].
Dickert, N ;
Grady, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :198-203
[6]   THE INSTITUTIONAL REVIEW BOARD AND BEYOND - FUTURE CHALLENGES TO THE ETHICS OF HUMAN-EXPERIMENTATION [J].
EDGAR, H ;
ROTHMAN, DJ .
MILBANK QUARTERLY, 1995, 73 (04) :489-&
[7]   What makes clinical research ethical? [J].
Emanuel, EJ ;
Wendler, D ;
Grady, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20) :2701-2711
[8]  
Faden RR, 1996, JAMA-J AM MED ASSOC, V276, P403
[9]  
GRILLOTCOURVALI.C, 2001, COMMUNICATION 0226
[10]  
HURIET C, 2000, 267